<p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>
- DOI
- 10.2147/jpr.s217563
- Published
- 2019-11
- Container
- Journal of Pain Research
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/jpr.s217563,
title = {\<p\>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy\</p\>},
author = {Sergio D Bergese and Marek Brzezinski and Gregory B Hammer and Timothy L Beard and Peter H Pan and Sharon E Mace and Richard D Berkowitz and Kristina Cochrane and Linda Wase and Harold S Minkowitz and Ashraf Habib},
year = {2019},
journal = {Journal of Pain Research},
doi = {10.2147/jpr.s217563},
url = {https://doi.org/10.2147/jpr.s217563}
}RIS
TY - JOUR TI - <p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p> AU - Sergio D Bergese AU - Marek Brzezinski AU - Gregory B Hammer AU - Timothy L Beard AU - Peter H Pan AU - Sharon E Mace AU - Richard D Berkowitz AU - Kristina Cochrane AU - Linda Wase AU - Harold S Minkowitz AU - Ashraf Habib PY - 2019 JO - Journal of Pain Research DO - 10.2147/jpr.s217563 UR - https://doi.org/10.2147/jpr.s217563 ER -
APA
Bergese, S. D., Brzezinski, M., Hammer, G. B., Beard, T. L., Pan, P. H., Mace, S. E., Berkowitz, R. D., Cochrane, K., Wase, L., Minkowitz, H. S., & Habib, A. (2019). <p>ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy</p>. Journal of Pain Research. https://doi.org/10.2147/jpr.s217563
Source records
- crossref · retrieved 2026-09-26T21:17:38.795Z